欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5461/001
药品名称Gaviscon Double Action Mixed Berries Flavour Chewable Tablets
活性成分
    • calcium carbonate 187.5 mg
    • sodium alginate 250.0 mg
    • sodium bicarbonate 106.5 mg
剂型Chewable tablet
上市许可持有人Reckitt Benckiser Healthcare B.V. Siriusdreef 14 2132 WT Hoofddorp Netherlands
参考成员国 - 产品名称Netherlands (NL)
Gaviscon Duo Bosvruchten, kauwtabletten
互认成员国 - 产品名称
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • Portugal (PT)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Gaviscon Max
    • Hungary (HU)
    • Germany (DE)
    • Bulgaria (BG)
      Gaviscon Double Action Mixed Berries Flavour
    • Denmark (DK)
      Galieve Extra
    • Romania (RO)
    • Belgium (BE)
    • Luxembourg (LU)
许可日期2023/08/02
最近更新日期2024/04/11
药物ATC编码
    • A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase